CKD Stage Classification for eGFR 45 mL/min/1.73 m²
An eGFR of 45 mL/min/1.73 m² with a serum creatinine of 1.19 mg/dL represents Stage 3a chronic kidney disease (CKD), specifically defined as moderately decreased kidney function in the eGFR range of 45-59 mL/min/1.73 m².
Understanding the Classification
The current KDIGO classification system stages CKD based on eGFR values rather than serum creatinine alone, as creatinine significantly underestimates kidney disease, particularly in older adults and women 1. Your eGFR of 45 mL/min/1.73 m² falls into Stage 3a CKD, which represents moderate kidney function decline 2.
Why Creatinine Alone Is Misleading
- Serum creatinine of 1.19 mg/dL may appear "normal" but masks significant kidney dysfunction when eGFR is calculated 1
- Among older adults with Stage 3 CKD, 80.6% had creatinine values ≤1.5 mg/dL, and 38.6% had values ≤1.2 mg/dL, demonstrating how creatinine alone misses the diagnosis 1
- The optimal creatinine cutoff for detecting Stage 3 CKD is ≥1.3 mg/dL for men and ≥1.0 mg/dL for women, but eGFR remains the gold standard 1
Stage 3 CKD Subdivisions
Stage 3 CKD is divided into two subcategories based on progression risk 3:
- Stage 3a: eGFR 45-59 mL/min/1.73 m² (your current stage)
- Stage 3b: eGFR 30-44 mL/min/1.73 m² (higher risk for progression)
Clinical Significance at Your Stage
At eGFR 45 mL/min/1.73 m², you are at the threshold where treatment intensification becomes critical 2. This level triggers specific therapeutic interventions:
- SGLT2 inhibitors are recommended if you have urine albumin-to-creatinine ratio (ACR) ≥200 mg/g, heart failure, or diabetes with eGFR ≥20 mL/min/1.73 m² 2
- SGLT2 inhibitors are suggested even with ACR <200 mg/g at eGFR 20-45 mL/min/1.73 m² (2B recommendation) 2
- ACE inhibitors or ARBs should be continued even as eGFR falls below 30 mL/min/1.73 m² 2
Important Clinical Caveats
Age Considerations
- If you are ≥70 years old, an eGFR of 45-59 mL/min/1.73 m² may represent age-appropriate kidney function if stable over time and without other markers of kidney damage (proteinuria, hematuria, structural abnormalities) 4
- However, this does not negate the Stage 3a classification—it simply contextualizes the clinical significance 4
Monitoring Requirements
- Confirm the diagnosis with repeat testing over 3 months to establish chronicity, as CKD requires persistent abnormality for >3 months 5
- Check urine albumin-to-creatinine ratio to complete staging, as albuminuria category (A1, A2, A3) significantly impacts prognosis and treatment decisions 5
- Assess for CKD complications including hyperkalemia, metabolic acidosis, hyperphosphatemia, vitamin D deficiency, and anemia 5
Equation Accuracy
- The eGFR calculation assumes use of standardized creatinine assays and validated equations (CKD-EPI 2021 or MDRD) 6, 7
- CKD-EPI equation performs with greater precision and accuracy than MDRD, particularly at eGFR values near 60 mL/min/1.73 m² 8
Risk Stratification
Your eGFR of 45 mL/min/1.73 m² places you at increased risk for:
- Cardiovascular disease and mortality 5
- Progression to end-stage kidney disease 5
- CKD-related complications requiring monitoring 5
High-risk features requiring nephrology referral include 5:
- eGFR <30 mL/min/1.73 m² (not yet applicable to you)
- Albuminuria ≥300 mg per 24 hours
- Rapid decline in eGFR (>5 mL/min/1.73 m² per year)